Indexed by:
Abstract:
USA and China are two leading countries engaged in nanotechnology research and development. They compete with each other for fruits in this innovative area in a parallel and compatible manner. Understanding the status and developmental prospects of nanotechnology in USA and China is important for policy-makers to decide nanotechnology priorities and funding, and to explore new ways for global cooperation on key issues. We here present the nanoscience and nanomedicine research and the related productivity measured by publications, and patent applications, governmental funding, policies and regulations, institutional translational research, industrial and enterprise growth in nanotechnology-related fields across China and USA. The comparison reveals some marked asymmetries of nanotechnology development in China and USA, which may be helpful for future directions to strengthen nanotechnology collaboration for both countries, and for the world as a whole. (C) 2015 Elsevier Inc. All rights reserved.
Keyword:
Reprint 's Address:
Email:
Version:
Source :
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
ISSN: 1549-9634
Year: 2016
Issue: 1
Volume: 12
Page: 13-19
5 . 7 2
JCR@2016
4 . 2 0 0
JCR@2023
ESI Discipline: CLINICAL MEDICINE;
ESI HC Threshold:215
JCR Journal Grade:1
CAS Journal Grade:2
Cited Count:
WoS CC Cited Count: 14
SCOPUS Cited Count:
ESI Highly Cited Papers on the List: 0 Unfold All
WanFang Cited Count:
Chinese Cited Count:
30 Days PV: 2
Affiliated Colleges: